Glucagon‐like peptide agonists: A prospective review
Abstract Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have emerged as promising therapeutic options for addressing Type‐2 diabetes, obesity, and related conditions. Among these, semaglutide, tirzepatide, liraglutide etc., all notable GLP‐1RA, have gained attention owing to their f...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2024-01-01
|
| Schriftenreihe: | Endocrinology, Diabetes & Metabolism |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/edm2.462 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|